Related Experiment Video

Updated: May 27, 2026

Murine Aortic Crush Injury: An Efficient In Vivo Model of Smooth Muscle Cell Proliferation and Endothelial Function
06:14

Murine Aortic Crush Injury: An Efficient In Vivo Model of Smooth Muscle Cell Proliferation and Endothelial Function

Published on: June 11, 2017

AMP-activated protein kinase and the control of smooth muscle cell hyperproliferation in vascular disease

Nicola Ferri1

  • 1Department of Pharmacological Sciences, Via Balzaretti 9, 20133, Milan, Italy. nicola.ferri@unimi.it

Vascular Pharmacology
|November 15, 2011
PubMed

Insights

Adenosine monophosphate-activated protein kinase (AMPK) inhibits vascular smooth muscle cell proliferation, a key factor in atherosclerosis. AMPK activation, through various mechanisms and drugs like nifedipine, shows therapeutic potential for preventing arterial lesions.

Area of Science:

  • Vascular Biology
  • Cellular Signaling
  • Pharmacology

Background:

  • Smooth muscle cell (SMC) accumulation in arteries drives atherosclerotic lesion formation.
  • Adenosine monophosphate-activated protein kinase (AMPK) is recognized as a significant inhibitor of SMC proliferation.
  • AMPK's anti-proliferative effects are linked to regulating cyclin-dependent kinase inhibitors (p21Cip1, p27Kip1) and inhibiting mTORC1.

Purpose of the Study:

  • To review the biological functions of AMPK in vascular SMC proliferation.
  • To summarize evidence for AMPK's role in in vivo intima hyperplasia.
  • To identify drugs that pharmacologically target AMPK for atheroprotection.

Main Methods:

  • Review of existing literature on AMPK, SMC proliferation, and atherosclerosis.
  • Analysis of in vivo studies using AMPK activators (e.g., AICAR) and AMPKα(-/-) mice.
  • Examination of drug-induced AMPK phosphorylation and its effects on vascular cells.

Main Results:

  • AMPK activation demonstrates a protective effect against intima hyperplasia in experimental models.
  • Drugs with antiproliferative properties, including nifedipine, have been shown to activate AMPK.
  • Nifedipine's atheroprotective action via AMPK is independent of its calcium channel blocking activity.

Conclusions:

  • AMPK plays a crucial role in regulating vascular SMC proliferation and preventing atherosclerotic lesion development.
  • Targeting AMPK represents a promising therapeutic strategy for treating and preventing atherosclerosis.
  • Further research into AMPK-activating drugs could yield novel atheroprotective therapies.

More Related Videos

Isolation of Primary Patient-specific Aortic Smooth Muscle Cells and Semiquantitative Real-time Contraction Measurements In Vitro08:28

Isolation of Primary Patient-specific Aortic Smooth Muscle Cells and Semiquantitative Real-time Contraction Measurements In Vitro

Published on: February 15, 2022

A Cell Culture Model of Resistance Arteries10:54

A Cell Culture Model of Resistance Arteries

Published on: September 8, 2017

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
Nitric Oxide Signaling Pathway01:28

Nitric Oxide Signaling Pathway

Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure to...
Smooth Muscle Contraction01:25

Smooth Muscle Contraction

Smooth muscle contraction is a complex process vital for various bodily functions, from maintaining blood vessel tension to facilitating the movement of food through the digestive tract. Unlike striated muscles, smooth muscle contraction begins more slowly and lasts longer.
The onset of contraction is triggered by an increase in calcium ions within the sarcoplasm, similar to the process in striated muscle. However, smooth muscles have a relatively smaller reservoir of the sarcoplasmic...
Autoregulation of Blood Flow01:17

Autoregulation of Blood Flow

Autoregulation mechanisms are characterized by their inherent capacity for self-regulation without necessitating specific nervous stimulation or endocrine control. These mechanisms facilitate the adjustment of blood flow and, therefore, perfusion specific to each tissue region. This self-regulation encompasses chemical signals and myogenic controls.
Chemical Signaling in Autoregulation
Chemical signaling operates at the precapillary sphincter level, inciting either contraction or relaxation.
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...